Emergency BU Alert BU Medical Campus OPEN Jan. 28, 2015 Boston University Medical Campus will be open Wednesday, Jan. 28, 2015. BUSM classes will be held as scheduled. Staff should check with their managers regarding work schedules. Medical, PA and GMS students who are assigned to inpatient services or clinics are expected to be present, if possible. Students who are assigned to outpatient services should check with their course director or the policy at the clinical site. GMS classes are canceled. Staff should check with their manager regarding their work schedules. The Henry M. Goldman School of Dental Medicine will follow normal school hours. All Patient Treatment Centers will be open for patient care and all classes will be held as scheduled. BU School of Public Health classes are canceled; SPH non-essential staff may telecommute. Employees who are part of the BUMC parking program should park in your assigned lot or garage. The Boston parking ban is still in effect. For updated information, please call the weather/emergency hotline at 617-638-6886 or visit the BU Emergency Communications website at http://www.bu.edu/ehs/comm/

Arthritis Center/Rheumatology


Boston University Arthritis Center is an internationally recognized center in research, patient care and education. The Center was established in 1983 to advance basic, clinical, and epidemiological research in rheumatology and to translate laboratory findings into new therapeutic strategies. The Center unifies extensive basic, translational and clinical research, medical education, and patient care. Arthritis Center faculty include faculty in general rheumatology, and also faculty within focused programs in Scleroderma, Vasculitis, and Clinical Epidemiology. Our multidisciplinary programs in scleroderma and vasculitis are highly integrated with experts in many specialties, including those in pulmonary/pulmonary hypertension. Clinical care is provided at the Boston Medical Center in state-of-the art out and in-patient facilities. The Center’s clinical research teams have been at the forefront of developing new approaches to study and test new treatments for scleroderma, osteoarthritis, vasculitis and other autoimmune disorders.